Innoviva, Inc. Business Operations Contracts & Agreements
12 Contracts & Agreements
- Collaboration Agreements (4 contracts)
- Indemnification Agreements (3)
- Management Agreements (1)
- Supply Agreements (2)
- Termination Agreements (2)
- Third Amendment to Collaboration Agreement, dated July 13, 2022, by and among Innoviva, Inc., Glaxo Group Limited, and Theravance Respiratory Company, LLC (Filed With SEC on July 13, 2022)
- Indemnification Agreement, dated as of March 9, 2021, by and between Innoviva, Inc. and Deborah L. Birx, M.D (Filed With SEC on April 28, 2021)
- Strategic Advisory Agreement, dated as of December 11, 2020, by and between Sarissa Capital Management LP and Innoviva, Inc (Filed With SEC on December 14, 2020)
- Form of Indemnification Agreement between Innoviva, Inc. and its directors and executive officers (Filed With SEC on September 11, 2018)
- [Signature Page to Termination Agreement] (Filed With SEC on February 28, 2017)
- PARTIAL TERMINATION AGREEMENT dated as of May 16, 2016 Between INNOVIVA, INC. and BANK OF AMERICA, N.A. (Filed With SEC on August 4, 2016)
- COLLABORATION AGREEMENT by and between THERAVANCE, INC. and GLAXO GROUP LIMITED Dated: November 14, 2002 (Filed With SEC on August 7, 2014)
- THERAVANCE COLLABORATION AGREEMENT AMENDMENT (Filed With SEC on March 6, 2014)
- COLLABORATION AGREEMENT by and between THERAVANCE, INC. and GLAXO GROUP LIMITED Dated: November 14, 2002 (Filed With SEC on November 1, 2013)
- TECHNOLOGY TRANSFER AND SUPPLY AGREEMENT (Filed With SEC on August 1, 2012)
- [AMENDED AND RESTATED] INDEMNIFICATION AGREEMENT (Filed With SEC on May 2, 2012)
- SUPPLY AGREEMENT TD-6424 ActivePharmaceutical Ingredient BY AND BETWEEN THERAVANCE, INC., SCINOPHARM TAIWAN,LTD. AND BIDDLE SAWYERPHARMA LLC (Filed With SEC on August 4, 2006)
